ClinicalTrials.gg
CompletedNCT00950898Updated Aug 3, 2009

The Acute Effects of Coffee on Glucose Metabolism

An interventional study of decaff and caffcoff in Type 2 Diabetes, sponsored by Brooklyn College of the City University of New York. Completed at 1 site in United States. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-08-03.

Sponsored by Brooklyn College of the City University of New York · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 3,308 studies in Diabetes Mellitus, Type 2 with a site in United States — 345 open to participants now, 480 under way, 51 of them phase 3. Diabetes Mellitus, Type 2 · United States.

Enrollment
2,730th of 2,961
11 · median 90
Started
2006
with 112 others
No phase
1,242 of 3,308
200 open now
Registered
773rd of 3,308
by date

Among the 3,308 studies in Diabetes Mellitus, Type 2 with a site in United States, this one is the 2,730th largest by enrollment of the 2,961 interventional ones that give a count, is one of 113 that started in 2006, is one of 1,242 with no phase, and was the 773rd registered.

Diabetes Mellitus, Type 2

10,402 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

345 of the 3,308 studies in Diabetes Mellitus, Type 2 with a site in United States are open now. Recruiting first, the newest first:

340 more — sign in →

All 345 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 880 Diabetes Mellitus, Type 2 studies recruiting now, 374 (43%) set no upper age limit and 381 (43%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years to 35 Years · male · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 3,308 studies in Diabetes Mellitus, Type 2 with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study was to determine the acute effects of decaffeinated coffee, caffeinated coffee and caffeine on glucose metabolism in humans

03

Conditions studied

  • Type 2 Diabetes

Keywords

  • coffee
  • caffeine
  • glucose metabolism
  • insulin sensitivity
  • diabetes
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy young males
  • nonsmokers
  • moderate alcohol users

Exclusion criteria

Exclusion Criteria:

  • not on any medications that could alter glucose metabolism
  • no history of blood disorders
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
11 participants (actual)

Interventions

  • Otherdecaff

    2 mugs of decaffeinated coffee

  • Othercaffcoff

    2 mugs of caffeinated coffee

  • Othercaffeine

    2 mugs of hot water containing caffeine

  • Otherplacebo

    2 mugs of hot water

06

What researchers measure

Primary outcomes

  1. plasma glucose levels

    Time frame: 0, 10, 30, 60, 90, and 120 minutes.

Secondary outcomes

  1. plasma insulin

    Time frame: 0, 10, 30, 60, 90, and 120 minutes

07

Study locations

1 site
  • Brooklyn College of the City University of New York
    Brooklyn, New York 11210, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2006, a primary completion of Jun 2007 and a completion of Jun 2007. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2009
First posted
Aug 3, 2009
Start
Nov 2006
Primary completionActual
Jun 2007
CompletionActual
Jun 2007
Last update
Aug 3, 2009
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 3, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00950898
Lead sponsor
Brooklyn College of the City University of New York
First posted
Aug 3, 2009
Start date
Nov 2006
Primary completion
Jun 2007
Completion
Jun 2007
Last update
Aug 3, 2009

Study contacts

James Greenberg, Ph.D.
principal investigator · Brooklyn College of the City University of New York

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion